<DOC>
	<DOCNO>NCT00473499</DOCNO>
	<brief_summary>The aim PEPCAD III substudy ass efficacy Paclitaxel-eluting DEBlue stent system treatment stenoses native coronary artery compare Sirolimus-eluting Cypher stent intravascular ultrasound ( IVUS ) study influence device endothelial function , coronary flow reserve , stem cell mobilization .</brief_summary>
	<brief_title>PEPCAD III Substudy : Stem Cell Mobilization</brief_title>
	<detailed_description>The aim PEPCAD III substudy ass efficacy DEBlue® Paclitaxel-eluting stent system treatment stenoses native coronary artery compare Sirolimus-eluting Cypher stent intravascular ultrasound ( IVUS ) study influence device endothelial function , coronary flow reserve , stem cell mobilization . This study prospective , randomize , single-center , two-armed phase-II study . During PEPCAD III trial , 40 patient Homburg / Saar center randomly assign ei-ther one treatment group ( 20 patient treated DEBlue , 20 patient Cypher® ) . Patients stable select form unstable angina document ischemia due significant lesion native coronary artery include . Vessels may supply en-tirely infarcted myocardial area . Additional 20 patient receive uncoated stent ( Coroflex® Blue , B.Braun ) undergo diagnostic procedure .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients stable unstable angina document ischemia due significant lesion native coronary artery Patients eligible coronary revascularization mean PCI Intention treat one lesion one stent Patients suitable coronary revascularization sort ( balloon angioplasty , deviceassisted balloonangioplasty , coronary artery bypass graft ) Patients must ≥ 18 year age Women childbearing potential may pregnant desire become pregnant first year follow study procedure . Hence , patient advise use adequate birth control method include 9 month followup Patients mentally linguistically able understand aim study show sufficient compliance follow study protocol Patients must agree undergo 9 month angiographic followup Patients must agree undergo 1 3 year clinical followup Patient able verbally acknowledge understand associate risk , benefit , treatment alternative therapeutic option trial , e.g . balloon angioplasty mean Paclitaxeleluting PTCAballoon catheter combination Coroflex BlueTM stent Sirolimuseluting CypherTM stent . The patient , provide informed consent , agree risk benefit state patient inform consent document . Significant stenosis native coronary artery nominal stent diameter ≥ 2.5 mm ≤ 3.5 mm &lt; 24 mm length Unprotected leave main In stent restenosis Indication one lesion treat , even stag procedure Intended bifurcational stenting Patients require chronic anticoagulation SVG AG Acute MI ( STEMI , NSTEMI ) Cardiogenic shock Chronic total occlusion Pregnancy Patients stand alone balloon angioplasty , stent deployment 6 month prior enrolment study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>drug elute balloon</keyword>
	<keyword>drug elute stent</keyword>
	<keyword>stem cell</keyword>
</DOC>